FTAI Aviation heads into its October 27 earnings date with short sellers steadily reducing exposure and the stock rebounding 7.5% on the week — yet the Street's mean price target sits nearly double the current price, a gap that frames the debate sharply.
Short interest has been on a clear downtrend. At 6.2% of the free float, it is down 11% from a month ago and has fallen from roughly 8 million shares in mid-August to just over 6.4 million today. That decline is orderly rather than dramatic — a slow bleed of bearish conviction, not a squeeze-driven unwind. The lending market supports this reading: borrow costs are a negligible 0.46%, and availability runs at 1,150% — meaning there are roughly eleven shares available to lend for every one already borrowed. There is no tension in the lending pool whatsoever. Options lean very mildly defensive, with the put/call ratio at 0.60, just above its 20-day average of 0.56 and only 1.3 standard deviations elevated. That is nowhere near the kind of hedging seen at the 52-week PCR high of 1.63. Overall, positioning looks more neutral than anything — bears are retreating, and new bears are not stepping in to replace them.
The Street is uniformly constructive on rating but noticeably divided on where the target belongs. Every analyst in the recent-changes log carries a Buy, Overweight, Outperform, or Market Outperform rating. Yet the targets have pulled in sharply. Barclays cut its target to $310 just last week, maintaining Overweight. That followed BTIG trimming from $400 to $350 in early August. Morgan Stanley moved the other way in late August, lifting its target from $319 to $360. The consensus mean lands at $364, implying about 92% upside from the current $189.74. That spread — unanimous bulls, wildly divergent targets — captures the stock's central tension. Bulls point to the fully committed $6bn SPV, the inaugural ABS issuance, expanding aerospace maintenance partnerships, and an adjusted 2027 EBITDA estimate of $2.6bn. Bears acknowledge the growth runway but flag that Q2 2026 EBITDA came in below consensus, 2027 estimates have been trimmed, and fuel prices remain a variable. The 30-day contraction in P/E (down from ~20.3x to 18.5x) and price-to-book (down from ~12.4x to 11.0x) reflects some multiple compression alongside the stock's 9.5% decline on the month, even as EV/EBITDA near 11.5x holds reasonable for the aftermarket model.
The most notable insider data point is from late July, when President David Moreno bought 2,475 shares at $201.27 for roughly $498,000 — an open-market purchase, not a grant or exercise, filed without a 10b5-1 plan declaration. That is a discretionary buy at a price above the current market, which at minimum signals the President did not view $201 as stretched. The broader insider picture in the 90-day window nets to only that purchase on the buy side; the other transactions are tax-withholding and grant activity, which carry no directional signal. Capital Research and Management holds a commanding 26.5% of shares and added about 414,000 shares in the most recent reporting period. BlackRock added 433,000 shares. Wellington Management, with 2.3% of the stock, added 794,000 shares in its last reported period — one of the larger percentage additions across the holder list. No 13D activist sits on the register; all major holders are passive 13G filers, and the disclosure note applies: stakes are as-last-disclosed around the 5% threshold.
The earnings history is worth watching as the October 27 date approaches. The most recent print, reported July 29, sent the stock down 7% on the day before recovering to a 5% gain on the week. The prior Q1 print moved FTAI up 4.4% on the day and 12% over the following five sessions. The pattern — volatile day-one reaction, stabilisation or recovery within the week — has been consistent. Given the stock is 9.5% lower on the month but 7.5% higher this week, the setup into earnings is one of partial recovery from a drawdown, with options not yet pricing in an elevated premium.
What to watch: whether the 7.5% weekly rebound holds into next week's tape, and whether Barclays' trimmed $310 target (the lowest bellwether print in the recent cluster) draws any further revisions downward ahead of the October 27 report.
See the live data behind this article on ORTEX.
Open FTAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
